What does Lionco Pharmaceutical Group Co.,Ltd. do?

Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 603669.SS's market cap?

Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) has a market capitalization of approximately $3.90 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 603669.SS pay a dividend?

Yes — Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 603669.SS profitable?

Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

603669.SS

Lionco Pharmaceutical Group Co.,Ltd.

SHH·Drug Manufacturers, Specialty & Generic · Healthcare

¥5.48¥0.12−2.14%

Market cap¥3.90B·Market closed·Aug 26 7:00 AM UTC

Price Chart

¥5.48−¥0.12 (−2.14%)today

−40.11%CAGR −9.75%

Select date range

FromTo

May 28, 2015Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)+18.0%

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.100

Ex-Dividend DateJul 5

Payment DateJul 5

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateApr 18

Last Report DateJun 30

Reported vs Estimate−¥0.03

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥408.33M

Net Income−¥136.39M

Net Margin−33.4%

Operating Cash Flow−¥108.12M

Capital Expenditures¥3.89M

Free Cash Flow−¥112.00M

Return on Equity−21.3%

Return on Invested Capital2.4%

Net Debt¥156.23M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 603669.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 603669.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 603669.SS and 80,000+ other tickers.

About Lionco Pharmaceutical Group Co.,Ltd.

Lionco Pharmaceutical Group Co., Ltd., in collaboration with its various subsidiaries, actively participates in the entire lifecycle of pharmaceutical products within China, from initial research and development to manufacturing and sales. The company boasts a comprehensive portfolio of therapeutic solutions, encompassing medications for nutritional support, antimicrobial and antiviral treatments, digestive disorders, cardiovascular health, detoxification, and anti-tumor therapies, alongside other specialized products. Furthermore, it maintains dedicated research institutes that focus…

CEO: Ling Ping Tao
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: SHH
Employees: 284
Website: www.lingkang.com.cn

Peers

Peers Tab

300086.SZ

Honz Pharmaceutical Co., Ltd.

Cap

¥3.1B

600568.SS

Zhongzhu Healthcare Holding Co.,Ltd

Cap

¥4.3B

300110.SZ

Huaren Pharmaceutical Co., Ltd.

Cap

¥3.4B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 603669.SS

What does Lionco Pharmaceutical Group Co.,Ltd. do?: Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 603669.SS's market cap?: Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) has a market capitalization of approximately $3.90 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 603669.SS pay a dividend?: Yes — Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 603669.SS profitable?: Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.